Pretreatment frequency of circulating IL-17+CD4+T-cells, but not Tregs, correlates with clinical response to whole-cell vaccination in prostate cancer patients (Q56986771)

From Wikidata

Jump to navigation Jump to search

article

edit

Language	Label	Description	Also known as
English	Pretreatment frequency of circulating IL-17+CD4+T-cells, but not Tregs, correlates with clinical response to whole-cell vaccination in prostate cancer patients	article

Statements

instance of

scholarly article

0 references

title

Pretreatment frequency of circulating IL-17+CD4+T-cells, but not Tregs, correlates with clinical response to whole-cell vaccination in prostate cancer patients (English)

0 references

main subject

patient

0 references

prostate cancer

1 reference

based on heuristic

inferred from title

author

Graham Pawelec

object named as

Graham Pawelec

series ordinal

7

0 references

author name string

Evelyna Derhovanessian

series ordinal

1

0 references

Victoria Adams

series ordinal

2

0 references

Karin Hähnel

series ordinal

3

0 references

Andrea Groeger

series ordinal

4

0 references

Hardev Pandha

series ordinal

5

0 references

Stephen Ward

series ordinal

6

0 references

language of work or name

English

0 references

publication date

15 September 2009

0 references

published in

International Journal of Cancer

0 references

volume

125

0 references

issue

6

0 references

page(s)

1372-1379

0 references

cites work

Administration of a CD25-directed immunotoxin, LMB-2, to patients with metastatic melanoma induces a selective partial reduction in regulatory T cells in vivo

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FIJC.24497

retrieved

21 January 2018

Cutting edge: Th17 and regulatory T cell dynamics and the regulation by IL-2 in the tumor microenvironment

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FIJC.24497

retrieved

21 January 2018

IL-17 enhances the net angiogenic activity and in vivo growth of human non-small cell lung cancer in SCID mice through promoting CXCR-2-dependent angiogenesis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FIJC.24497

retrieved

21 January 2018

Human peripheral blood T regulatory cells (Tregs), functionally primed CCR4+ Tregs and unprimed CCR4- Tregs, regulate effector T cells using FasL.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FIJC.24497

retrieved

21 January 2018

CD4+CD25high T cells are enriched in the tumor and peripheral blood of prostate cancer patients

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FIJC.24497

retrieved

21 January 2018

Analysis of the cellular mechanism of antitumor responses and autoimmunity in patients treated with CTLA-4 blockade

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FIJC.24497

retrieved

21 January 2018

Human T cells that are able to produce IL-17 express the chemokine receptor CCR6.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FIJC.24497

retrieved

21 January 2018

Identifiers

DOI

10.1002/IJC.24497

0 references

PubMed publication ID

19533748

0 references

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q56986771&oldid=1785707409"